^
BIOMARKER:
POLE mutation
i
Other names: POLE1, DNA Polymerase Epsilon Catalytic Subunit, DNA Polymerase Epsilon Catalytic Subunit A, Polymerase (DNA) Epsilon Catalytic Subunit, DNA Polymerase II Subunit A, Polymerase (DNA Directed) Epsilon Catalytic Subunit, DNA Polymerase Epsilon Catalytic Subunit Protein, Polymerase (DNA Directed) Epsilon
Entrez ID:
Related biomarkers:
POLE mutation
Endometrial Cancer
pembrolizumab
Sensitive
:
C2
POLE mutation
Gastric Cancer
CP-675206
Sensitive
:
C2
POLE mutation
Gastric Cancer
durvalumab
Sensitive
:
C2
POLE mutation
Solid Tumor
avelumab
Sensitive
:
C2
POLE mutation
Endometrial Cancer
avelumab
Sensitive
:
C2
POLE mutation
Solid Tumor
toripalimab
Sensitive
:
C2
POLE mutation
Melanoma
PD1 inhibitor + PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Cholangiocarcinoma
PD1 inhibitor + PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
NSCLC
PD1 inhibitor + PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
CRC
PD1 inhibitor + PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Melanoma
PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Cholangiocarcinoma
PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
NSCLC
PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
CRC
PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Melanoma
PD1 inhibitor
Sensitive
:
C3
POLE mutation
Cholangiocarcinoma
PD1 inhibitor
Sensitive
:
C3
POLE mutation
NSCLC
PD1 inhibitor
Sensitive
:
C3
POLE mutation
CRC
PD1 inhibitor
Sensitive
:
C3
POLE mutation
Endometrial Cancer
nivolumab
Sensitive
:
C4
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our